HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.56

Change

-0.01 (-0.12)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.16 (+0.46%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

+0.15 (+0.71%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.22 (+0.58%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.19 (-0.74%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.03 (+0.29%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.05 (+0.22%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.65% 84% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.65% 84% B 78% C+
Trailing 12 Months  
Capital Gain -1.27% 6% D- 17% F
Dividend Return 4.73% 78% C+ 68% D+
Total Return 3.46% 12% F 19% F
Trailing 5 Years  
Capital Gain 5.68% 36% F 44% F
Dividend Return 39.61% 95% A 93% A
Total Return 45.29% 64% D 57% F
Average Annual (5 Year Horizon)  
Capital Gain 3.60% 53% F 46% F
Dividend Return 4.28% 54% F 42% F
Total Return 0.68% 82% B 34% F
Risk Return Profile  
Volatility (Standard Deviation) 7.30% 67% D+ 84% B
Risk Adjusted Return 58.56% 73% C 69% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike